Exodus Point Capital Management, LP Shattuck Labs, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
A detailed history of Exodus Point Capital Management, LP transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 15,633 shares of STTK stock, worth $56,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,633Holding current value
$56,904% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STTK
# of Institutions
73Shares Held
23.3MCall Options Held
130KPut Options Held
163K-
Redmile Group, LLC San Francisco, CA5.62MShares$20.4 Million1.98% of portfolio
-
Prosight Management, LP Dallas, TX3.73MShares$13.6 Million9.58% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.37MShares$8.63 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.82MShares$6.62 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.66MShares$6.05 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $154M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...